MetLife price target raised to $93 from $92 at Wells Fargo

Wells Fargo analyst Elyse Greenspan raised the firm’s price target on MetLife (MET) to $93 from $92 and keeps an Overweight rating on the shares. The firm notes MetLife’s Q3 was marred by weak group results, but management had a positive tone on group life experience and underlying disability results, while they had an upbeat view on dental heading into 2025. In terms of positive developments with the LTC risk transfer space, the company noted that it is seeing a somewhat narrowing of the bid-ask spread over the last 12 months, Wells adds.